Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic c

[News]

Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according to findings published in Proceedings of the National Academy of Sciences.

More... (https://www.news-medical.net/news/20220201/Neural-stem-cells-plus-HER2-inhibitor-drug-improve-survival-in-mice-with-metastatic-cancer.aspx)